Who Prioritizes Innovation? R&D Spending Compared for Texas Instruments Incorporated and Manhattan Associates, Inc.

Comparing R&D priorities: Texas Instruments vs. Manhattan Associates

__timestampManhattan Associates, Inc.Texas Instruments Incorporated
Wednesday, January 1, 2014489530001358000000
Thursday, January 1, 2015538590001280000000
Friday, January 1, 2016547360001370000000
Sunday, January 1, 2017577040001508000000
Monday, January 1, 2018718960001559000000
Tuesday, January 1, 2019876080001544000000
Wednesday, January 1, 2020842760001530000000
Friday, January 1, 2021976280001554000000
Saturday, January 1, 20221118770001670000000
Sunday, January 1, 20231268140001863000000
Monday, January 1, 20241376890001959000000
Loading chart...

Igniting the spark of knowledge

Innovation in Focus: A Tale of Two Companies

In the ever-evolving landscape of technology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Texas Instruments Incorporated and Manhattan Associates, Inc. have demonstrated contrasting approaches to R&D investment.

From 2014 to 2024, Texas Instruments consistently allocated a significant portion of its resources to R&D, with expenditures growing by approximately 44% over this period. In 2023 alone, the company invested nearly 1.9 billion dollars, underscoring its dedication to maintaining a competitive edge in the semiconductor industry.

Conversely, Manhattan Associates, a leader in supply chain and omnichannel commerce, has shown a steady increase in R&D spending, albeit on a smaller scale. Their investment rose by about 181% from 2014 to 2024, reflecting a strategic focus on enhancing their software solutions.

This comparison highlights the diverse strategies companies employ to prioritize innovation, each tailored to their unique market demands and growth objectives.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025